Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer

被引：0
|
作者：
Mccall, N. S. [1 ]
Switchenko, J. M. [1 ]
Tian, S. [1 ]
Stokes, W. A. [1 ]
Kahn, S. [1 ]
Kesarwala, A. H. [1 ]
Shelton, J. W. [1 ]
Szabo, S. M. [1 ]
Steuer, C. E. [1 ]
Carlisle, J. W. [1 ]
Ramalingam, S. S. [1 ]
Bradley, J. D. [1 ]
Leal, T. [1 ]
Higgins, K. A. [1 ]
机构：
[1] Emory Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Small cell lung cancer; radiation; lurbinectedin;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP14.03-00
引用
收藏
页码：S541 / S541
页数：1
相关论文
共 50 条
  • [31] Outcomes and prognostic Factors after Radiotherapy for Patients with "extensive disease" Stage small cell Lung Cancer
    Ziegler, D. A.
    Ziegler, S.
    Droge, L. H.
    Cleve, C. C.
    Fischer, L. A.
    Guhlich, M.
    Donath, S.
    Schirmer, M. A.
    Braulke, F.
    Overbeck, T.
    Hinterthaner, M.
    Rieken, S.
    El Shafie, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S107 - S107
  • [32] Lurbinectedin in small cell lung cancer
    Manzo, Anna
    Sforza, Vincenzo
    Carillio, Guido
    Palumbo, Giuliano
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Mercadante, Edoardo
    La Manna, Carmine
    Muto, Paolo
    Totaro, Giuseppe
    De Cecio, Rossella
    Picone, Carmine
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Extensive stage small cell lung cancer
    Johnson, BE
    LUNG CANCER, 2004, 46 : S9 - S9
  • [34] A Phase II Study of Biweekly Irinotecan and Cisplatin for Patients With Extensive Stage Disease Small Cell Lung Cancer
    Ryoo, H.
    Bae, S.
    Hyun, M.
    Lee, K.
    Kim, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S623 - S623
  • [35] A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer
    Bae, Sung Hwa
    Ryoo, Hun Mo
    Do, Young Rok
    Song, Hong Suk
    Kwon, Ki Young
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Lee, Won Sik
    Hur, In Kyong
    Baek, Jin Ho
    Park, Keon Uk
    LUNG CANCER, 2008, 59 (01) : 76 - 80
  • [36] A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer
    Lee, Won Silk
    Bae, Sung Hwa
    ANNALS OF ONCOLOGY, 2007, 18 : 183 - 184
  • [37] A phase II study of biweekly irinotecan plus cisplatin in patients with extensive stage small cell lung cancer
    Bae, S.
    Kim, M.
    Shin, S.
    Lee, K.
    Hyun, M.
    Song, H.
    Kwon, K.
    Park, K.
    Lee, W.
    EJC SUPPLEMENTS, 2005, 3 (02): : 338 - 338
  • [38] Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Gadgeel, Shirish M.
    Pennell, Nathan A.
    Fidler, Mary Jo
    Halmos, Balazs
    Bonomi, Philip
    Stevenson, James
    Schneider, Bryan
    Sukari, Ammar
    Ventimiglia, Jaclyn
    Chen, Wei
    Galasso, Cathy
    Wozniak, Antoinette
    Boerner, Julie
    Kalemkerian, Gregory P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : 1393 - 1399
  • [39] Understanding Real-Life Response to Lurbinectedin as Second Line Therapy in Patients with Extensive Stage Small-Cell Lung Cancer
    Curt, K.
    Rice, J.
    Qin, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S705 - S706
  • [40] Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study
    C Tibaldi
    T Prochilo
    F Russo
    M C Pennucci
    A Del Freo
    F Innocenti
    A Fabbri
    A Falcone
    P F Conte
    E Baldini
    British Journal of Cancer, 2006, 94 : 1263 - 1266
12345